Rationale and design of the Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE): interim analysis at 30 days of the first 180 patients enrolled

Aim. The Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE) is a long-term 1200-patient multicenter prospective study initiated to augment the knowledge base (poolable and comparable) about endovascular aortic repair (EVAR) in a real-world population implanted with a single l...

Full description

Saved in:
Bibliographic Details
Main Authors: Böckler, Dittmar (Author) , Fitridge, R. (Author) , Wolf, Y. (Author) , Hayes, P. (Author) , Silveira, P. (Author) , Numan, Füruzan (Author) , Riambau, V. (Author)
Format: Article (Journal)
Language:English
Published: 2010
In: The journal of cardiovascular surgery
Year: 2010, Volume: 51, Issue: 4, Pages: 481-491
ISSN:1827-191X
Online Access:Verlag, lizenzpflichtig, Volltext: https://avesis.istanbul.edu.tr/yayin/ad4cf0db-5be6-49aa-a34b-04fd1d248850/rationale-and-design-of-the-endurant-stent-graft-natural-selection-global-postmarket-registry-engage-interim-analysis-at-30-days-of-the-first-180-patients-enrolled
Get full text
Author Notes:D. Böckler, R. Fitridge, Y. Wolf, P. Hayes, P. Silveira, Füruzan Numan, V. Riambau; ENGAGE Investigators
Description
Summary:Aim. The Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE) is a long-term 1200-patient multicenter prospective study initiated to augment the knowledge base (poolable and comparable) about endovascular aortic repair (EVAR) in a real-world population implanted with a single latest-generation stent graft system (Endurant). With enrollment ongoing at 80 high-volume sites, the registry has limited inclusion/exclusion criteria or procedural specification. Technical and clinical data will be reported through 5 years.
Item Description:Gesehen am 17.02.2023
Physical Description:Online Resource
ISSN:1827-191X